Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Charter Hall Group (CHC.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-28	16.77	20.00	Neutral
2022-06-17	10.80	-	No Rating
2022-06-20	11.10	13.90	Buy
2022-08-26	13.40	15.25	Buy
2022-12-07	12.40	14.20	Neutral
2023-02-21	13.58	14.00	Neutral
2023-06-20	11.12	12.30	Neutral
2023-11-22	10.09	11.25	Neutral
2024-05-31	12.12	12.20	Neutral
2024-07-05	11.17	11.93	Neutral
2024-08-22	14.51	12.80	Sell
2024-09-24	16.12	14.00	Sell
2025-02-21	17.53	15.49	Sell

Disclosures

Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.